VHL down-regulation and differential localization as mechanisms in tumorigenesis

Kidney International

Volumn 64, Issue 5, 2003, Pages 1671-1674

  Shiao, Yih Horng ^a   Forsti, Asta ^b   Egevad, Lars ^b   Anderson, Lucy M ^b   Lindblad, Per ^b   Hemminki, Kari ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Down regulation; Immunohistochemistry; Localization; Membrane; Renal tumor; Von Hippel Lindau

Indexed keywords

PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER CELL; CANCER STAGING; CARCINOGENESIS; CELL MEMBRANE; CELL TYPE; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0142187245     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00257.x     Document Type: Article

References (22)

1. NEUMANN HP, LIPS CJ, HSIA YE, ZBAR B: Von Hippel-Lindau syndrome. Brain Pathol 5:181-193, 1995
2. KAELIN WG, JR: Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2:673-682, 2002
3. PUGH CW, RATCLIFFE PJ: The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin Cancer Biol 13:83-89, 2003
4. SHIAO YH: The von Hippel-Lindau gene and protein in tumorigenesis and angiogenesis: a potential target for therapeutic designs. Curr Med Chem 10:2461-2470, 2003
5. GNARRA JR, TORY K, WENG Y, et al: Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85-90, 1994
6. GNARRA JR, DUAN DR, WENG Y, et al: Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1242:201-210, 1996
7. SHIAO YH, RICE JM, ANDERSON LM, et al: von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J Natl Cancer Inst 90:1720-1723, 1998
8. LOS M, JANSEN GH, KAELIN WG, et al: Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 75:231-238, 1996
9. CORLESS CL, KIBEL AS, ILIOPOULOS O, KAELIN WG, JR: Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum Pathol 28:459-464, 1997
10. SAKASHITA N, TAKEYA M, KISHIDA T, et al: Expression of von Hippel-Lindau protein in normal and pathological human tissues. Histochem J 31:133-144, 1999
11. YAO M, YOSHIDA M, KISHIDA T, et al: VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma. J Natl Cancer Inst 94:1569-1575, 2002
12. SHIAO YH, RAMAKRISHNA G, ANDERSON LM, et al: Down-regulation of von Hippel-Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors. Cancer Lett 179:33-38, 2002
13. SHIAO YH, DIWAN BA, PERANTONI AO, et al: Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers. Mol Carcinog 19:230-235, 1997
14. YANG K, LINDBLAD P, EGEVAD L, HEMMINKI K: Novel somatic mutations in the VHL gene in Swedish archived sporadic renal cell carcinomas. Cancer Lett 141:1-8, 1999
15. MA X, YANG K, LINDBLAD P, et al: VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium. Oncogene 20:5393-5400, 2001
16. HEMMINKI K, JIANG Y, MA X, et al: Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors. Carcinogenesis 23:809-815, 2002
17. ROBSON CJ, CHURCHILL BM. ANDERSON W: The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297-301, 1969
18. KIBEL A, ILIOPOULOS O, DECAPRIO JA, KAELIN WG, JR: Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269:1444-1446, 1995
19. SHIAO YH, RESAU JH, NAGASHIMA K, et al: The von Hippel-Lindau tumor suppressor targets to mitochondria. Cancer Res 60:2816-2819, 2000
20. SHIAO YH: Role of the von Hippel-Lindau gene and protein in kidney tumor phenotypes: animal models. Rec Res Dev Histopathol 1:21-37, 2002; www.researchsignpost.com
21. MAGYARLAKI T, BUZOGANY I, NAGY J: Specific von Hippel-Lindau protein expression of clear cell renal cell carcinoma with "immunogenic" features. Pathol Oncol Res 7:42-45, 2001
22. WIJNHOVEN BP, LINDSTEDT EW, ABBOU M, et al: Molecular genetic analysis of the von Hippel-Lindau and human peroxisome proliferator-activated receptor gamma tumor-suppressor genes in adenocarcinomas of the gastroesophageal junction. Int J Cancer 94:891-895, 2001